Update shared on09 Aug 2025
Fair value Increased 2.20%With both Net Profit Margin and Consensus Revenue Growth forecasts remaining stable, analysts have left their fair value estimate for Somnigroup International unchanged at $80.89.
What's in the News
- Somnigroup International completed a follow-on equity offering, raising $953.36 million through the sale of 15,376,743 common shares at $62 per share with a $0.458 per share discount.
- A follow-on equity offering for 15,376,743 common shares was filed.
- A 31-day lock-up period for certain common stock held by directors and executive officers is in place from May 12 to June 12, restricting sales or transfers without underwriter consent.
- Q2 2025 earnings results are expected to be reported on August 7, 2025.
Valuation Changes
Summary of Valuation Changes for Somnigroup International
- The Consensus Analyst Price Target remained effectively unchanged, at $80.89.
- The Net Profit Margin for Somnigroup International remained effectively unchanged, at 10.63%.
- The Consensus Revenue Growth forecasts for Somnigroup International remained effectively unchanged, at 12.8% per annum.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.